218 related articles for article (PubMed ID: 16171463)
1. Role of cysteine residues in the function of human UDP glucuronosyltransferase isoform 1A1 (UGT1A1).
Ghosh SS; Lu Y; Lee SW; Wang X; Guha C; Roy-Chowdhury J; Roy-Chowdhury N
Biochem J; 2005 Dec; 392(Pt 3):685-92. PubMed ID: 16171463
[TBL] [Abstract][Full Text] [Related]
2. Bilirubin UDP-glucuronosyltransferase 1 is the only relevant bilirubin glucuronidating isoform in man.
Bosma PJ; Seppen J; Goldhoorn B; Bakker C; Oude Elferink RP; Chowdhury JR; Chowdhury NR; Jansen PL
J Biol Chem; 1994 Jul; 269(27):17960-4. PubMed ID: 8027054
[TBL] [Abstract][Full Text] [Related]
3. Required buried alpha-helical structure in the bilirubin UDP-glucuronosyltransferase, UGT1A1, contains a nonreplaceable phenylalanine.
Ciotti M; Cho JW; George J; Owens IS
Biochemistry; 1998 Aug; 37(31):11018-25. PubMed ID: 9692996
[TBL] [Abstract][Full Text] [Related]
4. Genetic lesions of bilirubin uridine-diphosphoglucuronate glucuronosyltransferase (UGT1A1) causing Crigler-Najjar and Gilbert syndromes: correlation of genotype to phenotype.
Kadakol A; Ghosh SS; Sappal BS; Sharma G; Chowdhury JR; Chowdhury NR
Hum Mutat; 2000 Oct; 16(4):297-306. PubMed ID: 11013440
[TBL] [Abstract][Full Text] [Related]
5. Rapid proteasomal degradation of translocation-deficient UDP-glucuronosyltransferase 1A1 proteins in patients with Crigler-Najjar type II.
Ohnishi A; Emi Y
Biochem Biophys Res Commun; 2003 Oct; 310(3):735-41. PubMed ID: 14550264
[TBL] [Abstract][Full Text] [Related]
6. Influence of mutations associated with Gilbert and Crigler-Najjar type II syndromes on the glucuronidation kinetics of bilirubin and other UDP-glucuronosyltransferase 1A substrates.
Udomuksorn W; Elliot DJ; Lewis BC; Mackenzie PI; Yoovathaworn K; Miners JO
Pharmacogenet Genomics; 2007 Dec; 17(12):1017-29. PubMed ID: 18004206
[TBL] [Abstract][Full Text] [Related]
7. Genetic predisposition to the metabolism of irinotecan (CPT-11). Role of uridine diphosphate glucuronosyltransferase isoform 1A1 in the glucuronidation of its active metabolite (SN-38) in human liver microsomes.
Iyer L; King CD; Whitington PF; Green MD; Roy SK; Tephly TR; Coffman BL; Ratain MJ
J Clin Invest; 1998 Feb; 101(4):847-54. PubMed ID: 9466980
[TBL] [Abstract][Full Text] [Related]
8. Activation of glucuronidation through reduction of a disulfide bond in rat UDP-glucuronosyltransferase 1A6.
Ikushiro S; Emi Y; Iyanagi T
Biochemistry; 2002 Oct; 41(42):12813-20. PubMed ID: 12379124
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of inherited deficiencies of multiple UDP-glucuronosyltransferase isoforms in two patients with Crigler-Najjar syndrome, type I.
Bosma PJ; Chowdhury JR; Huang TJ; Lahiri P; Elferink RP; Van Es HH; Lederstein M; Whitington PF; Jansen PL; Chowdhury NR
FASEB J; 1992 Jul; 6(10):2859-63. PubMed ID: 1634050
[TBL] [Abstract][Full Text] [Related]
10. Function, genetic polymorphism, and transcriptional regulation of human UDP-glucuronosyltransferase (UGT) 1A1.
Sugatani J
Drug Metab Pharmacokinet; 2013; 28(2):83-92. PubMed ID: 23089802
[TBL] [Abstract][Full Text] [Related]
11. Crigler-Najjar syndrome in The Netherlands: identification of four novel UGT1A1 alleles, genotype-phenotype correlation, and functional analysis of 10 missense mutants.
Sneitz N; Bakker CT; de Knegt RJ; Halley DJ; Finel M; Bosma PJ
Hum Mutat; 2010 Jan; 31(1):52-9. PubMed ID: 19830808
[TBL] [Abstract][Full Text] [Related]
12. Influence of N-terminal domain histidine and proline residues on the substrate selectivities of human UDP-glucuronosyltransferase 1A1, 1A6, 1A9, 2B7, and 2B10.
Kerdpin O; Mackenzie PI; Bowalgaha K; Finel M; Miners JO
Drug Metab Dispos; 2009 Sep; 37(9):1948-55. PubMed ID: 19487247
[TBL] [Abstract][Full Text] [Related]
13. Regulation of the UGT1A1 bilirubin-conjugating pathway: role of a new splicing event at the UGT1A locus.
Lévesque E; Girard H; Journault K; Lépine J; Guillemette C
Hepatology; 2007 Jan; 45(1):128-38. PubMed ID: 17187418
[TBL] [Abstract][Full Text] [Related]
14. Expression and inducibility of the human bilirubin UDP-glucuronosyltransferase UGT1A1 in liver and cultured primary hepatocytes: evidence for both genetic and environmental influences.
Ritter JK; Kessler FK; Thompson MT; Grove AD; Auyeung DJ; Fisher RA
Hepatology; 1999 Aug; 30(2):476-84. PubMed ID: 10421657
[TBL] [Abstract][Full Text] [Related]
15. Isolation and characterization of a UDP-glucuronosyltransferase (UGT1A01) cloned from female rhesus monkey.
Dean B; Chang S; Stevens J; Thomas PE; King C
Arch Biochem Biophys; 2002 Jun; 402(2):289-95. PubMed ID: 12051676
[TBL] [Abstract][Full Text] [Related]
16. A novel intronic mutation results in the use of a cryptic splice acceptor site within the coding region of UGT1A1, causing Crigler-Najjar syndrome type 1.
Sappal BS; Ghosh SS; Shneider B; Kadakol A; Chowdhury JR; Chowdhury NR
Mol Genet Metab; 2002 Feb; 75(2):134-42. PubMed ID: 11855932
[TBL] [Abstract][Full Text] [Related]
17. Glucuronidation of antiallergic drug, Tranilast: identification of human UDP-glucuronosyltransferase isoforms and effect of its phase I metabolite.
Katoh M; Matsui T; Yokoi T
Drug Metab Dispos; 2007 Apr; 35(4):583-9. PubMed ID: 17220234
[TBL] [Abstract][Full Text] [Related]
18. UGT1A1 gene mutations in Pakistani children suffering from inherited nonhemolytic unconjugated hyperbilirubinemias.
Khan S; Irfan M; Sher G; Zubaida B; Alvi MA; Yasinzai M; Naeem M
Ann Hum Genet; 2013 Nov; 77(6):482-7. PubMed ID: 23992562
[TBL] [Abstract][Full Text] [Related]
19. Activation of the mouse TATA-less and human TATA-containing UDP-glucuronosyltransferase 1A1 promoters by hepatocyte nuclear factor 1.
Bernard P; Goudonnet H; Artur Y; Desvergne B; Wahli W
Mol Pharmacol; 1999 Sep; 56(3):526-36. PubMed ID: 10462540
[TBL] [Abstract][Full Text] [Related]
20. A phenylalanine codon deletion at the UGT1 gene complex locus of a Crigler-Najjar type I patient generates a pH-sensitive bilirubin UDP-glucuronosyltransferase.
Ritter JK; Yeatman MT; Kaiser C; Gridelli B; Owens IS
J Biol Chem; 1993 Nov; 268(31):23573-9. PubMed ID: 8226884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
